Compare Hims and Hers Health Inc (HIMS) vs JPMorgan Ultra Short Income ETF (JPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs JPMorgan Ultra Short Income ETF — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while JPMorgan Ultra Short Income ETF trades at $50.3 (market cap $42.37B). The key difference: JPMorgan Ultra Short Income ETF is far larger — about 6.5× Hims and Hers Health Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and JPMorgan Ultra Short Income ETF for 47 Days on average.
| HIMS | JPST | |
|---|---|---|
Market Cap | $6.55B | $42.37B |
Volume | 14,842,814 | 7,889,185 |
Sector | Health | Fixed Income |
52-Week High | $62.76 | $50.78 |
52-Week Low | $14.52 | $50.22 |
Typical Hold Time | 21 Days | 47 Days |
Enterprise Value | $7.25B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $30.92, up 4.67% on the day, amid a bearish technical signal and significant legal headwinds from multiple securities class action lawsuits. The stock shows mixed fundamentals with strong revenue growth to $2.35 billion in 2025 but a sharp reversal to a net loss of -$142 million in 2026, reflecting profitability challenges. Valuation ratios appear elevated with a P/E of 57.14 and EV/EBITDA of 205.86, while analyst consensus remains cautiously optimistic with a $32.17 price target.
The outlook is clouded by legal risks and recent earnings misses, though the company's gross margin of 68.43% indicates underlying business strength. Investment opportunity hinges on resolving regulatory scrutiny and returning to profitability, but near-term volatility is likely. Key risks include the FTC lawsuit outcome and sustained negative cash flow, demanding careful risk assessment by investors.
JPMorgan Ultra-Short Income ETF (JPST) trades at $50.30 with minimal daily movement, showing stability typical of ultra-short bond funds. Technical indicators signal bearish momentum with moving averages in sell territory, though oversold RSI levels suggest potential near-term stabilization. Recent news highlights institutional position adjustments and growing investor interest in cash-alternative ETFs amid rising rate expectations.
The ETF faces headwinds from active management costs and competitive pressure from similar funds, though demand for ultrashort duration assets provides support. Key risks include interest rate sensitivity and fund flow volatility, while institutional ownership changes indicate mixed sentiment among professional investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →
